SMS Pharmaceuticals, founded in 1990 and headquartered in Hyderabad, India, is a leading producer of Active Pharmaceutical Ingredients (APIs) and intermediates. The company manufactures a broad range of APIs, particularly in therapeutic areas like anti-ulcer, anti-fungal, anti-viral, and cardiovascular drugs. With state-of-the-art manufacturing facilities that meet international regulatory standards, including US FDA and EDQM approvals, SMS Pharmaceuticals exports to over 70 countries worldwide. The company is also heavily invested in research and development, focusing on innovation and complex chemistry to meet global pharmaceutical needs while ensuring strict regulatory compliance.